Bosentan in Digital Ulcers — RAPIDS 2 OL

Digital Ulcers Clinical Trial

Official title:
Long-term Bosentan Open Label Extension of the AC-052-331 Study in Systemic Sclerosis Patients With Ischemic Digital Ulcers

Status Completed

Clinical Trial Summary

The aim of the study is to collect long-term efficacy, tolerability and safety data of bosentan in Systemic Sclerosis (SSc) patients suffering from ischemic digital ulcers (DUs).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00319696
Study type	Interventional
Source	Actelion
Contact
Status	Completed
Phase	Phase 3
Start date	July 8, 2004
Completion date	January 22, 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02915835` - Riociguat in Scleroderma Associated Digital Ulcers	Phase 2
Completed	`NCT02800993` - Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma	Phase 3
Completed	`NCT00077584` - Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma	Phase 3
Completed	`NCT01117298` - A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma	Phase 3
Completed	`NCT01395732` - Bosentan in Systemic Sclerosis	Phase 4
Completed	`NCT01377090` - Digital Ulceration	N/A